Panacea Life Sciences Holdings, Inc. (PLSH) stock
PLSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through Q1 FY2024, quarter ended Mar 31, 2024Last filing: 10-Q on May 6, 2024
$0.07+0.00 (+5.45%)
Close on Oct 19, 2026Market cap $1.15MP/E –Yield –
Panacea Life Sciences operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Panacea Life Sciences's operating income for the twelve months ending Mar 31, 2024 was -$5.31M. For fiscal 2023 it was -$5.55M. The highest annual figure on record is -$389.28K in fiscal 2015.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | -$5.55M | – |
| FY2022 | Dec 31, 2022 | -$5.65M | – |
| FY2021 | Dec 31, 2021 | -$5.94M | – |
| FY2020 | Dec 31, 2020 | -$5.26M | – |
| FY2019 | Dec 31, 2019 | -$10.67M | – |
| FY2018 | Dec 31, 2018 | -$2.44M | – |
| FY2017 | Dec 31, 2017 | -$3.12M | – |
| FY2016 | Dec 31, 2016 | -$1.60M | – |
| FY2015 | Dec 31, 2015 | -$389.28K | – |
| FY2014 | Dec 31, 2014 | -$420.26K | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2024 | Mar 31, 2024 | -$1.06M | – |
| Q4 FY2023 | Dec 31, 2023 | -$1.77M | – |
| Q3 FY2023 | Sep 30, 2023 | -$1.41M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.07M | – |
| Q1 FY2023 | Mar 31, 2023 | -$1.29M | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.38M | – |
| Q3 FY2022 | Sep 30, 2022 | -$1.39M | – |
| Q2 FY2022 | Jun 30, 2022 | -$1.24M | – |
| Q1 FY2022 | Mar 31, 2022 | -$1.65M | – |
| Q4 FY2021 | Dec 31, 2021 | -$2.15M | – |
| Q3 FY2021 | Sep 30, 2021 | -$1.26M | – |
| Q2 FY2021 | Jun 30, 2021 | -$1.44M | -279.3% |
| Q1 FY2021 | Mar 31, 2021 | -$1.09M | – |
| Q4 FY2020 | Dec 31, 2020 | -$1.72M | – |
| Q3 FY2020 | Sep 30, 2020 | -$3.35M | – |
| Q2 FY2020 | Jun 30, 2020 | $802.64K | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.63M | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.95M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.02M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.02M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.60M | – |
| Q4 FY2018 | Dec 31, 2018 | -$584.70K | – |
| Q3 FY2018 | Sep 30, 2018 | -$425.93K | – |
| Q2 FY2018 | Jun 30, 2018 | -$296.20K | – |
| Q1 FY2018 | Mar 31, 2018 | -$1.38M | – |
| Q4 FY2017 | Dec 31, 2017 | -$1.53M | – |
| Q3 FY2017 | Sep 30, 2017 | -$490.21K | – |
| Q2 FY2017 | Jun 30, 2017 | -$506.30K | – |
| Q1 FY2017 | Mar 31, 2017 | -$601.01K | – |
| Q4 FY2016 | Dec 31, 2016 | -$747.43K | – |
| Q3 FY2016 | Sep 30, 2016 | -$359.81K | – |
| Q2 FY2016 | Jun 30, 2016 | -$260.87K | – |
| Q1 FY2016 | Mar 31, 2016 | -$233.37K | – |
| Q4 FY2015 | Dec 31, 2015 | -$69.65K | – |
| Q1 FY2015 | Mar 31, 2015 | -$64.02K | – |
| Q4 FY2014 | Dec 31, 2014 | -$240.45K | – |
| Q3 FY2014 | Sep 30, 2014 | -$74.89K | – |
| Q2 FY2014 | Jun 30, 2014 | -$17.10K | – |
See a number that looks wrong?